Comparison of three anthrax toxin neutralization assays

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Anthrax toxin neutralization assays are vital for evaluating antibody responses to vaccines.
• Recombinant protective antigen (rPA) vaccines are a key strategy for anthrax prophylaxis.
• Standardization of assay methods is needed for reliable vaccine efficacy assessment.

Purpose of the Study:

• To compare the comparability of three common toxin neutralization assays: J774A.1 cell-, RAW 264.7 cell-, and CHO cell-based assays.
• To assess the agreement of these assays in measuring neutralization activities of sera from animals and humans vaccinated with rPA.
• To identify potential sources of variability in assay results.

Main Methods:

• Sera from rabbits, nonhuman primates, and humans vaccinated with rPA were tested.
• Neutralization titers were measured using J774A.1 cell-, RAW 264.7 cell-, and CHO cell-based assays.
• Assay results were normalized against a common reference serum sample for comparative analysis.

Main Results:

• Good quantitative agreement was observed between assays for later serum samples from rabbits.
• Some heterogeneity in neutralization estimates was noted for early serum samples.
• Relative neutralization estimates varied across species, with differences attributed to Fc receptor-mediated neutralization in cell-based assays.
• Discrepancies among assays were generally small, less than 2.5-fold.

Conclusions:

• While generally comparable, differences exist in toxin neutralization assays, particularly for early immune responses and across different species.
• Fc receptor-mediated neutralization contributes to assay variability.
• Consideration of these assay-specific differences is important for interpreting anthrax vaccine efficacy data.